Please sign in to follow a disease.
Bayer
Clinical trials sponsored by Bayer, explained in plain language.
Now part of
Bayer AG
BAYN
XETRA
A multinational pharmaceutical and life sciences company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- One-Time gene therapy could free hemophilia patients from frequent infusions Results expected Sep 2026 (estimated)
- Could a cancer drug alter Metformin's effects? a trial investigates Results expected Sep 2026 (estimated)
- Real-World study tracks darolutamide use in advanced prostate cancer Results expected Sep 2026 (estimated)
- 50,000 patients to reveal how new kidney drug works in real life Results expected Sep 2026 (estimated)
- MS drug use in pregnancy under the microscope: is it safe for baby? Results expected Sep 2026 (estimated)